Abstract
SUMMARYWhole-body counting over a three- to four-week period following the intravenous administration of copper 67 in 11 normal volunteers, 2 neurological control patients, 7 control subjects with cirrhosis, and 10 homozygotes and 7 heterozygotes of Wilson's disease showed that whole-body retention of radio-copper was prolonged in the wilsonian subjects, both homozygous and heterozygous, and in cirrhotic patients with ascites or hepatocellular failure or both.
If the latter can be excluded, prolonged whole-body retention of radiocopper serves to identify the presence of the abnormal gene or allele of Wilson's disease. Because of overlap, it is not possible to distinguish the heterozygote from the homozygote by whole-body counting alone.
External probe counting over the liver and muscle, carried out in 5 control subjects, 8 homozygotes, and 5 heterozygotes, revealed abnormal hepatic uptake with little apparent release of radiocopper and usually evident uptake in muscle in the homozygotes and reasonably normal hepatic uptake with delayed release and no apparent muscle uptake in the heterozygotes, compared with the control subjects.
It appears that external monitoring of hepatic and muscle radioactivity, in addition to whole-body turnover measurements after intravenous copper 67, permits more accurate determination of the genetic status of individuals in respect to Wilson's disease.
- © 1970 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
